To examine the effect of bariatric surgery on longitudinal serum urate levels in patients with obesity, categorized by preoperative hyperuricemia and diabetes status, specifically defining 'longitudinal' as measurements taken at multiple time points post-surgery.
Key Findings:
Significant weight reduction was observed over 24 months.
Mean serum urate levels decreased from 0.343 mmol/L at baseline to 0.296 mmol/L at 12 months and 0.286 mmol/L at 24 months, with p-values indicating statistical significance.
Patients with elevated baseline urate levels showed significant reductions by 4 months, while those with normal levels did not show significant changes until 12 months.
Patients with diabetes had smaller reductions in serum urate levels compared to those without diabetes, suggesting a potential link to insulin resistance.
Interpretation:
Bariatric surgery leads to significant reductions in serum urate levels in patients with obesity, with the most pronounced effects seen in those with elevated baseline levels. The smaller reductions in diabetic patients may relate to insulin resistance affecting urate clearance, which warrants further investigation.
Limitations:
Retrospective design may limit causal inferences, as it does not allow for controlled experimentation.
Lack of assessment of renal function's impact on urate levels post-surgery, which could provide additional insights.
Conclusion:
Bariatric surgery is effective in reducing serum urate levels in patients with obesity, with implications for reducing gout risk. Further research is needed to explore the relationship between urate levels and renal function post-surgery, particularly in diabetic patients.
